Scotts MiracleGro (SMG)
(Real Time Quote from BATS)
$76.50 USD
+6.08 (8.63%)
Updated Jul 31, 2024 10:46 AM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
SMG 76.50 +6.08(8.63%)
Will SMG be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SMG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SMG
Scotts (SMG) Reports Q3 Earnings: What Key Metrics Have to Say
Scotts Miracle-Gro (SMG) Tops Q3 Earnings Estimates
SMG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Scotts Miracle-Gro (SMG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
PPG Industries (PPG) Q2 Earnings Top Estimates, Sales Lag
Scotts (SMG) Lowers FY24 EBITDA Guidance, Affirms FCF View
Other News for SMG
Scotts: Fiscal Q3 Earnings Snapshot
ScottsMiracle-Gro Reports Fiscal 2024 Third Quarter Results
Scotts Miracle-Gro Co (SMG) Q3 Earnings: GAAP EPS Soars to $2.28, Revenue Hits $1. ...
Scotts Miracle-Gro Non-GAAP EPS of $2.31 beats by $0.39, revenue of $1.2B in-line
Scotts Miracle-Gro reaffirms non-GAAP 2024 guidance